Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
National Taiwan University Hospital
University of Michigan Rogel Cancer Center
Merck Sharp & Dohme LLC
City of Hope Medical Center
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
BeOne Medicines
University of Vermont
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
University of Oxford
Children's Oncology Group
Children's Oncology Group
Radiation Therapy Oncology Group
Bristol-Myers Squibb
Radiation Therapy Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb
Incyte Corporation
Mayo Clinic
National Cancer Institute (NCI)
University of Southern California
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Sanford Health
Bristol-Myers Squibb
Dana-Farber Cancer Institute
University of Washington
BeiGene
Merck Sharp & Dohme LLC
BeiGene
GERCOR - Multidisciplinary Oncology Cooperative Group
BeiGene
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Eli Lilly and Company
Ohio State University Comprehensive Cancer Center
AIDS Malignancy Consortium
GOG Foundation
AstraZeneca
Memorial Sloan Kettering Cancer Center
University of Chicago
University of Chicago
Merck Sharp & Dohme LLC